Letroxyl

KALPA PHARMACEUTICALS LETROXYL

Letroxyl, manufactured by Kalpa Pharmaceuticals, is a medication containing Letrozole as its active ingredient. Letrozole is a non-steroidal aromatase inhibitor used primarily in the treatment of estrogen-dependent breast cancer.

DRUG COMPOSITION

Each Letroxyl tablet contains:

• Letrozole 2.5 mg

PHARMACEUTICAL FORM

Letroxyl is available in the form of oral tablets for easy and convenient administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic and immunomodulating agents; ATC code: L02BG04.

PHARMACOLOGICAL PROPERTIES

Letroxyl is an aromatase inhibitor that works by reducing estrogen levels in postmenopausal women. It inhibits the enzyme aromatase, thereby preventing the conversion of androgens to estrogens.

PROFILE

• Chemical name: 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
• Chemical formula: C17H11N5
• Percentage of anabolic activity: Not a steroid
• Percentage of androgenic activity: Not a steroid
• Active half life: 2 days
• Recommended dosage: 0.5-2.5 mg/day
• Acne: no
• Bloating (water retention): no
• HBR: no
• Hepatic toxicity: no
• Aromatization: Inhibits aromatase, preventing estrogen conversion

THERAPEUTICAL INDICATIONS

Letroxyl is indicated for the treatment of breast cancer in postmenopausal women, particularly those with hormone receptor-positive tumors.

DOSES AND METHOD OF ADMINISTRATION

The dosage of Letroxyl should be determined by a healthcare professional based on individual patient characteristics. It is typically taken orally once a day, with or without food.

CYCLE/STACKING

Solo cycle:

• Weeks 1-5: Letroxyl (2.5 mg daily)

Cutting cycle:

• Weeks 1-8: Letroxyl (2.5 mg daily)
• Weeks 1-12: Oxandroxyl (20 mg daily)

Bulking cycle:

• Letroxyl is not typically used in bulking cycles due to its specific anti-estrogenic properties.

POST CYCLE THERAPY

PCT after a cycle with aromatizable steroids:

• Weeks 1-4: Letroxyl (2.5 mg every other day)
• Weeks 1-4: Clomixyl (50 mg daily)

SIDE EFFECTS

Possible side effects of Letroxyl may include hot flashes, joint pain, and fatigue. It is important to discuss potential side effects with a healthcare provider.

CONTRAINDICATIONS

Letroxyl is contraindicated in pregnant women, individuals with a known hypersensitivity to Letrozole, and premenopausal women.

OVERDOSE

In the case of an overdose, seek immediate medical attention. Symptoms may include severe dizziness and fainting.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Caution should be exercised in patients with liver disease or a history of osteoporosis. Regular monitoring is recommended.

INTERACTIONS WITH OTHER DRUGS

Letroxyl may interact with medications that affect liver enzymes. Inform healthcare providers of all medications being taken.

PRESENTATION, PACKAGING

2.5 mg/tablet, 30 tablets in sachet.

STORAGE

Store Letroxyl at room temperature, away from moisture and heat. Keep it out of reach of children.

LEGAL STATUS

Letroxyl is available only with a prescription and is subject to the regulations of each jurisdiction.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Kalpa Pharmaceuticals
India

EXTERNAL LINKS

• Letrozole Wiki, wikipedia.org
• Letrozole Uses, Side Effects & Warnings, drugs.com
• Letrozole Oral: Uses, Side Effects, Interactions, Pictures, medlineplus.gov.